Last reviewed · How we verify
NCT03678064
Use of the LOK® Robotic Gait Trainer in the Early Rehabilitation of Children After an Acquired Brain Injury (ABI)
NA trial testing Lokomat in Injury, Brain in 7 participants. Completed in 15 March 2020.
15 March 2020
Quick facts
| Lead sponsor | Holland Bloorview Kids Rehabilitation Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 7 |
| Start date | 5 June 2018 |
| Primary completion | 15 March 2020 |
| Estimated completion | 15 March 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Lokomat
Conditions studied
- Injury, Brain — all drugs for Injury, Brain →
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Who can join
Adults 5 to 18, any sex, with Injury, Brain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
After an acquired brain injury (ABI), children often require extensive physiotherapy (PT) to help them relearn to walk. There is promising evidence in pediatric neuro-motor conditions of the possibility for brain activation pattern changes in response to repetitive, task-oriented functional gait training. Robotic-assisted gait training devices such as the Lokomat (LOK) allow this type of intensive walking retraining. The aim of this study is to assess the safety, feasibility and outcome possibilities linked to a LOK intervention given as 2 of the child's 4 PT weekly sessions over 8-weeks in the early stages of rehabilitation after an ABI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03678064
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lokomat
Trials testing the same drug.
- NCT06164197 — Virtual Reality Based Robotic Gait and Balance Trainer · NA · completed
- NCT05811494 — Effectiveness of Multiple Robotic Gait-Devices for Improving Walking Ability in Subacute Stroke Patients · NA · withdrawn
- NCT05767268 — Assessment of the Psychophysical State During Rehabilitation Treatment With Lokomat · completed
Other Holland Bloorview Kids Rehabilitation Hospital trials
Trials by the same sponsor.
- NCT07360171 — Validity Assessment of Sensors for Movement Tracking With Children/Youth With Diverse Neuromotor Abilities · not yet recruiting
- NCT04041713 — A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome · Phase 2 · not yet recruiting
- NCT06341127 — Fluoxetine in KCNC1-related Disorder · NA · completed
- NCT03710343 — Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study · Phase 2 · completed
- NCT06129058 — Home-based Transcranial Direct Current Stimulation (tDCS) to Promote Social Communication and Behaviour in Children With · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03678064 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Holland Bloorview Kids Rehabilitation Hospital
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678064.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing